ST-01

N/A

Report date: 2022/12/03 23:08:07
NME

Base Information

Drug NameST-01
Drug Alias NameST-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsChronic PainPain, PostoperativeHeart Failure +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSaillant Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesSustained Therapeutics IncThe University Of British ColumbiaSaillant Therapeutics BV
Inactive CompaniesN/A
Active IndicationsChronic PainPain, PostoperativeHeart Failure +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A